# Seoul Pharma signs $97M supply deal for tadalafil ODF with Chinese GHC

Seoul Pharmaceutical announced a 10-year contract to supply its tadalafil orally disintegrating film (ODF) product to Chinese company GHC, valued at approximately 1,111 billion won ($97.25 million).

- Type: Contract
- Announced: 2017-06-22
- Where: China
- Value: $97.3M
- Status: announced
- Products: tadalafil orally disintegrating film (ODF)
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Seoul Pharmaceutical](https://endata.com/companies/25853.md) (supplier)
- [GHC](https://endata.com/companies/25854.md) (customer)

## Sources

- [medipharmnews.com](https://www.medipharmnews.com/news/articleView.html?idxno=90336), 2017-07-26: "서울제약(대표: 김정호)은 중국 GHC社에 자사의 타다라필 ODF(구강 붕해 필름) 제품을 10년간 약 1,111억원(미화 9,725만 달러)어치를 공급키로 계약했다고 공시했다."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.